Cartalax
Also known as: Ala-Glu-Asp
Cartalax is a synthetic tripeptide (Ala-Glu-Asp / AED) from the Khavinson bioregulator series, studied in Russian preclinical models on fibroblast and chondrocyte cultures. Not FDA-approved; no Western clinical trials exist, and all published evidence originates from a single research group.
Pricing for Cartalax
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
COAs for Cartalax
23 third-party tests across 7 vendors. Each card links to the full report.
For
Cartalax
by Verified Peptides· batch CAR0626042OD
For
Cartalax
by Ion Peptide· batch CART20-04022026
For
Cartalax
by Verified Peptides· batch 09-25-030C
For
Cartalax
by BioLongevity Labs· batch 35-3-46057
For
Cartalax
by Ion Peptide· batch CX20-012026
For
Cartalax
by Mile High Compounds· batch CAR-025-MH-01
For
Cartalax
by Real Peptides
For
Cartalax
by BioLongevity Labs· batch A
For
Cartalax
by BioLongevity Labs· batch 251617
For
Cartalax
by Skye Peptides· batch CTX25-25-002
For
Cartalax
by BioLongevity Labs· batch 35-1-45834
For
Cartalax
by BioLongevity Labs· batch QC251142
For
Cartalax
by Verified Peptides· batch 01-25-0510F
For
Cartalax
by Glacier Aminos· batch CLX20GA01
Purity not on file
For
Cartalax
by Ion Peptide· batch CX20-05162026
Purity not on file
For
Cartalax
by Verified Peptides· batch 09-25-030C
Purity not on file
For
Cartalax
by Real Peptides
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 35-3-45958
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 251617
Purity not on file
For
Cartalax
by Skye Peptides· batch CTX25-25-002
Purity not on file
For
Cartalax
by Skye Peptides· batch CTX25-25-002
Purity not on file
For
Cartalax
by BioLongevity Labs· batch 36-3-45777
Purity not on file
For
Cartalax
by Certified Peptides· batch 260203CX203
3 citations indexed for Cartalax
rct · 2025
Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study
Malnutrition is a common challenge in patients with pancreatic cancer undergoing cephalic pancreaticoduodenectomy (CPD), impacting postoperative recovery and overall prognosis. Nutritional support plays a crucial role in optimising metabolic, inflammatory, and digestive outcomes.
review · 2022
Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers
Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action.
review · 2021
Peptide Regulation of Gene Expression: A Systematic Review
Peptides are characterized by their wide range of biological activity: they regulate functions of the endocrine, nervous, and immune systems.